Mercer Global Advisors
IMVT icon

Mercer Global Advisors’s Immunovant IMVT Stock Holding History

Mercer Global Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+3,746
New +$114K ﹤0.01% 3540

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Mercer Global Advisors's IMVT Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Immunovant (IMVT) in Q2 2026: 3,746 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #3540 among its holdings.

212 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Mercer Global Advisors held 3,746 shares of Immunovant worth $144K as of Q2 2026.
  • Immunovant was a new Mercer Global Advisors position in Q2 2026.
  • Immunovant made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3540 holding.
  • 212 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.